# Research log — 2026-08-29 (Saturday)

## [10:57 ET] SETUP
- Weekend run. US equities and futures cash sessions closed; CME futures reopen Sun 18:00 ET.
- Per config/strategy.md weekend behavior: lean crypto + event contracts for actionable,
  treat equities as week-ahead prep with entries for the next open (Mon 2026-08-31).
- Prior context read: 20 open positions, 14 awaiting entry, 9 closed trades 0/9 (n<15 = noise, do not over-fit).
- URGENT carryover: /MBTU6 SHORT and BTC SELL positions are ~22% offside (BTC ~77.6k vs 63-64k entries,
  66,600 stop long since breached). Prior two runs already flagged the cover. Must re-state.
- Repetition guard: VST 4x, DHT 4x, NKE 3x, GLD 3x, NVDA 3x, DG 3x, TLT 3x, EEM 3x in last 10 days.
  Do not re-pitch these without a concrete change.

## [11:00 ET] MACRO — Friday 2026-08-28 close (all equity prices are prev close, market CLOSED)
- SPY 769.35, -0.23% (prev close 771.10; open 771.76, H 775.30, L 768.31) — source: finnhub via market_data.py
- QQQ 716.43, -0.65% (prev 721.11) — mild tech underperformance
- IWM 295.75, -1.35% (prev 299.81; closed near the low 295.67) — small caps led the downside
- GLD 408.89, **-3.24%** (prev 422.60; open 422.24, H 424.79, L 407.62) — the single biggest move on the tape Friday
- TLT 82.88, -0.30% (prev 83.13)
- VIXY 17.66, +1.79%
- FRED: US10Y 4.67% (08-27), US2Y 4.20% (08-27), fed funds eff 3.63% (08-27), 10y-2y +39bp (08-28), U3 4.1% (Jul)
- Crypto (24/7, live 14:57 UTC): BTC 77,991 (-1.98% 24h), ETH 2,447.28 (-2.67%), SOL 105.30 (-1.13%),
  XRP 1.40 (-2.56%), DOGE 0.0856 (-2.59%), LINK 11.46 (-3.30%), AVAX 7.36 (-1.12%), ADA 0.2023 (-4.14%)
  — source: coingecko via market_data.py
- **Regime read:** long end is stubborn (10y 4.67% with fed funds at 3.63% = ~104bp of positive carry-free
  term premium), curve only +39bp, and gold just broke hard while equities were only mildly lower.
  A -3.2% day in gold with bonds flat is NOT a rate shock — it is a positioning unwind in gold itself.
- **DATA GAP:** Yahoo Finance returned HTTP 429 for the whole session; ^GSPC/^NDX/^DJI/^RUT/^VIX/DXY/
  ES/NQ/gold-futures/WTI all failed every fallback. No VIX index level, no DXY, no crude, no index futures.
  Equity single-name quotes DO work via finnhub. Record this in data_quality_notes.

## [11:00 ET] CALENDAR — dated earnings catalysts inside 10 sessions (finnhub earnings calendar)
- Mon 2026-08-31 bmo: SAIC
- Tue 2026-09-01 amc: **DELL** (rev est 45.85B), **PANW** (3.42B); bmo MDT, NIO; M (Macy's)
- Wed 2026-09-02 amc: **AVGO** (29.95B, eps 3.30) — the week's biggest print; SNOW, HPE, NTAP, GOLD(Barrick), FIVE, WOOF
- Thu 2026-09-03 amc: **LULU** (2.51B, eps 1.83) <-- I HAVE AN OPEN LULU POSITION; ZS, DOCU; bmo CIEN, CPB, TTC
- Tue 2026-09-08: CASY, UNFI, ABM
- Wed 2026-09-09: KR (35.6B), CHWY, RH, AEO, ASO, SIG, CNM, COO, CPRT
- Thu 2026-09-10 amc: **ADBE** (6.82B, eps 6.20)

## [11:05 ET] MACRO — **REGIME CHANGE: Warsh Jackson Hole debut, market flips to pricing HIKES**
This is the single most important fact on the tape and it reframes every idea below.
- Kevin Warsh is Fed Chair. Gave his first Jackson Hole speech Fri 2026-08-28.
- Content: "impressed" with economic strength; concerned "underlying trends" in inflation have NOT
  improved; the Fed "has more work to do"; explicitly refused to give forward guidance or a
  reaction function; advocated a "quieter" central bank.
  — sources: https://www.washingtonpost.com/business/2026/08/28/fed-chair-warsh-speaks-jackson-hole-conference/
             https://www.cnbc.com/2026/08/28/kevin-warsh-jackson-hole-federal-reserve-inflation.html
             https://www.npr.org/2026/08/28/nx-s1-5947903/federal-reserve-inflation-jackson-hole-interest-rates
- **Market reaction: odds of a September HIKE went from ~1-in-3 pre-speech to a majority of investors
  expecting a hike. Bond market priced in a hike swiftly.** Consensus read: maybe not September, but
  a hike by October or December. — source: https://qz.com/fed-chair-kevin-warsh-jackson-hole-speech-082826
- Cross-check against Friday's tape, which is consistent: GLD -3.24% (no-yield asset, hawkish repricing),
  IWM -1.35% (small caps are the most rate-sensitive cohort), QQQ -0.65%, SPY -0.23%, VIXY +1.79%.
- **The tell nobody should miss: TLT was only -0.30%.** A hawkish shock that moves gold 3.2% and
  barely moves the 20y+ long bond is the market saying it finds the inflation-fighting credible.
  Short-end-up / long-end-anchored is a *flattener*, not a bond bear market. 10y-2y is already only +39bp.
- Position implications flagged now, worked through below:
  - open TLT long: NOT obviously wrong — the long end held. Re-examine, do not panic-close.
  - open BTC/[MBTU6] shorts: the regime just turned in their favour, but they are ~22% offside and
    long past their stated 66,600 stop. A stop is a stop. Still a close.
  - open gold-adjacent / GLD @398 awaiting entry: the level was not reached; now nearer after -3.2%.
  - the previously published KXFEDDECISION-26SEP-H25 YES @ 32c (a bet ON a September hike) is now
    directionally validated by the speech.

## [11:12 ET] EVENT CONTRACTS — live Kalshi prices (public trades + orderbook endpoints work; the
`market_data.py events` search does NOT — it keyword-matched "Fed" to a baseball pitcher named Fedde.
Note that as a tooling gap.)
Sep 16 2026 FOMC (close 2026-09-16 17:59Z):
- H25 hike 25bp: last 47c, bid/ask 46/47
- H0  no change:  last 54c, bid/ask 53/54
- C25 cut 25bp:   1c    | H26 hike >25bp: 1-2c
Oct 28 2026 FOMC: H25 hike 28c (bid/ask 25/29), H0 no change 70/71
Dec 9 2026 FOMC:  H25 hike last 50c but bid/ask 42/50 (8c wide = illiquid, do not trade), H0 44/45
- Reading the strip: Sept hike 47%, Oct hike 28%, Dec hike ~45%. Under independence that is only a
  ~17% chance of no hike at all in 2026; correlation makes the true figure higher, but the market is
  clearly pricing a hiking cycle as the base case off one speech.
- **CAPTURED: YES on KXFEDDECISION-26SEP-H0 @ 54c.** The disagreement is specifically about *timing*,
  not direction: Warsh did not signal September, refused forward guidance outright, and the same
  analysts driving the repricing say the hike lands in October or December. I put September at ~30-35%,
  the market at 47%. Buying no-change at 54c is economically the same as selling the hike at 46/47c.
- VENUE CHECK PASSED: Robinhood carries this exact event —
  https://robinhood.com/us/en/prediction-markets/economics/events/fed-rate-decision-in-september-2026-sep-16-2026/
- REJECTED — KXFEDDECISION-26DEC-*: 42/50 bid-ask. An 8-cent spread eats the entire edge. No trade.
- NOTE against the record: the 2026-08-22 report published YES on the *hike* leg (H25) at 32c and it
  never filled. Recommending the other side today is not a reversal of view at the same price — 32c
  for a hike was cheap, 47c is not. Different price, different trade. Say so plainly in the report.

## [11:14 ET] POSITION REVIEW — fresh Friday 2026-08-28 closes vs. prior_context (several prior_context
"Last" figures were stale; these are the fetched ones, source finnhub)
| Sym | Entry | Stop | Target | Fri close | Chg Fri | Read |
| XLE | 60.8/60.5/60.8 | 57.8/58.6/59.2 | 64.5-67 | 62.68 | +0.63% | in profit, stops intact |
| CCJ | 95 / 88 | none | 135 | 100.01 | **-5.94%** | needs a reason — investigate |
| NKE | 40 / 38 | none | 62-65 | 39.60 | +3.02% | flat-ish |
| PFE | 25.8 | none | 38 | 27.96 | -0.21% | +8.4% |
| DHT | 18.8 / 19.4 | 17.6/17.9 | 22.5 | 19.66 | +1.60% | fine |
| LCII | 94 | none | 138 | 102.96 | +0.65% | +9.5% |
| BCC | 81 | 76 | 92 | 78.75 | -0.03% | -2.8%, above stop |
| TJX | 150.85 | **145.5** | 163 | 135.12 | +0.67% | **STOP BREACHED — -10.4%. Should already be closed.** |
| TLT | 82.6 | 80.95 | 86.2 | 82.88 | -0.30% | +0.3%, above stop |
| LULU | 115 | none | 180 | 120.81 | **+5.05%** | +5.1%, EARNINGS Sep 3 amc |
| DINO | 93 | 86.5 | 108 | 99.71 | +2.79% | +7.2% |
Awaiting-entry levels vs Friday close: VST 137.09 (bids 134/128 unfilled), CEG 276.75 (bid 266),
DG 122.89 (bid 119), EEM 67.14 (bid 65.6). None reached; all still working.

## [11:20 ET] POSITION UPDATE — /MBTU6 — CLOSE (captured, conviction 5)
- decision: buy to cover both short contracts at the Sunday 18:00 ET CME reopen, at market.
- why: 66,600 stop breached ~2026-08-20 and never honoured; BTC now ~77,991, +21.7% vs the 64,220
  average entry. The bear case got its catalyst on Friday — Warsh told Jackson Hole inflation is too
  high and the market repriced to hiking — and BTC fell under 2%. IBIT is 33.7% off its 120-day low and
  above its 20-day (39.09) and 50-day (37.08). A hawkish shock that crypto shrugs off is a failed thesis.
- THIRD consecutive report requesting this. 08-25 and 08-26 both ranked it first. Still open.
- DATA GAP: could not fetch the actual /MBT futures quote (Yahoo 429 all session). Used CoinGecko BTC
  spot as an explicitly-labelled proxy. Flag in data_quality_notes.

## [11:21 ET] POSITION UPDATE — TJX — CLOSE (captured, conviction 5)
- decision: sell the 2026-08-19 long (@150.85) at the Monday 08-31 open.
- why: the 145.50 stop was breached and ignored; loss is now 10.4%. Fri close 135.12 = 1.18% above the
  120-day low of 133.55, 9.5% under the 20-day (149.26), 11.7% under the 50-day (153.05), 20.5% off the
  120-day high of 170.00. ATR14 3.30 (2.44%). Downtrend, not a base.

## [11:22 ET] POSITION UPDATE — CCJ — HOLD, no add
- Friday -5.94% to 100.01 was **sector-wide, not company-specific**: the decline mirrored uranium funds
  broadly; Cameco's Toronto line fell 2.57% to C$131.77, ~C$1.5B of market cap.
  — source: https://ts2.tech/en/cameco-stocks-c1-5-billion-slide-is-four-times-quarterly-ebitda-as-uranium-shares-retreat/
- Context still supportive: long-term uranium contract prices at multi-year highs and Kazakhstan trimmed
  its 2026 output plan. The overhang is the late-July earnings miss — higher realised uranium pricing vs
  weaker sales volumes and operating friction.
- Two open lots (95.00 and 88.00, target 135, no stop) are both in profit. Warsh-hawkish is a headwind
  for a long-duration commodity equity, which is a reason not to add here, not a reason to sell.
- decision: HOLD both, add nothing at 100. Not captured as a recommendation — no change to levels means
  nothing for the reader to act on.

## [11:03 ET] TIMESTAMP CORRECTION
Earlier headings in this file were written from an estimate of elapsed time, not from `date`, and run
roughly 10-15 minutes ahead of the true clock. Actual start 10:57 ET; actual time here 11:03 ET.
Content and prices are unaffected — every price above carries its own fetched `asof`. Timestamps from
this point are read from `date`.

## [11:05 ET] CALENDAR — confirmed macro dates (verified, not assumed)
- **Fri 2026-09-04 08:30 ET — August Employment Situation (nonfarm payrolls).**
  — source: https://www.bls.gov/schedule/news_release/current_year.asp
- **Fri 2026-09-11 08:30 ET — August CPI** (BLS lists Real Earnings for August on 09-11, and Real
  Earnings is released alongside CPI). — source: https://www.bls.gov/schedule/
- **Wed 2026-09-16 14:00 ET — FOMC decision** (meeting Sep 15-16), statement 14:00, presser 14:30.
  Remaining 2026 meetings after that: Oct 27-28, Dec 8-9.
  — source: https://www.federalreserve.gov/monetarypolicy/fomccalendars.htm
- Note that a 2025-dated FXStreet article surfaced in search claiming Labor Day fell on Sep 1 and NFP on
  Sep 5 — that is the 2025 calendar. In 2026 Labor Day is Mon Sep 7 and the Aug jobs report is Fri Sep 4.
  The finnhub earnings calendar independently corroborates: prints on Sep 1/2/3 and Sep 8/9/10, nothing
  on Sep 7. Discarded the 2025 article.
- **This materially strengthens the Sep-hold event-contract thesis:** September is an SEP/dot-plot
  meeting. A new chair who has publicly refused forward guidance still has to publish a dot plot, and
  a hawkish dot plot is the obvious way to signal a tightening path *without spending a hike* at his
  first meeting. Hold-and-signal is the cheapest option available to him, and it resolves my contract YES.
- Both prints that could force his hand (Sep 4 payrolls, Sep 11 CPI) land before the meeting, and the
  CPI lands only three sessions before it. That is the risk, and it is stated in the candidate.

## [11:06 ET] POSITION UPDATE — LULU — TRIM HALF into the pop, hold the core (captured, conviction 3)
- Fri 08-28: LULU +5.2% to 120.81 — and the news that day was UBS **cutting** its target to $120
  (from $124), Neutral maintained. The stock closed *above* the freshly-lowered target. That is
  pre-print positioning and bargain-hunting, not information.
  — source: https://wp.madrestravels.com/2026/08/28/lululemon-athletica-jumps-5-2-after-ubs-maintains-neutral/
- The print is Thu 2026-09-03 amc, call 16:30 ET. Company's own guide: revenue $2.45-2.475B (-2/-3%),
  North America down low double digits, gross margin -410bp (150bp of it tariffs), consensus EPS $1.79
  = -42.3% YoY. UBS flags the full-year profit outlook may be cut on this print.
  — source: https://www.tikr.com/blog/lululemon-reports-q2-earnings-september-3-what-the-stock-needs-to-show
- INSIDERS (checked, per the standing rule): 3 open-market buys, 2 distinct buyers, $1.99M over 6 months
  vs $100K sold. Board chair Charles Bergh bought 4,275 @117.05 (2026-06-15) and 6,090 @164.20
  (2026-03-20); Andre Maestrini 3,275 @151.02. Real signal, and it supports the *long-term* case
  specifically — but two of the three lots are far underwater, so it is not a timing signal.
- ARITHMETIC that drives the call: target 180, bear case 88 (below the 120-day low of 104.44, which is
  where a full-year guidance cut plausibly takes it). At 120.81 that is (180-120.81)/(120.81-88) = 1.80,
  against a 2.5 long-term floor. Adding here fails this report's own rule. Breakeven for the 2.5 floor
  is 114.29 — hence the 114.00 re-add level.
- decision: TRIM HALF at 120-121 before the Wed 09-02 close; hold half through the print; re-accumulate
  only at/below 114. LULU 120-day: last 120.81, ATR14 4.36 (3.61%), SMA20 121.06, SMA50 117.81,
  range 104.44-171.34, -29.5% off high.

## [11:07 ET] POSITION UPDATE — TLT — HOLD, stop unchanged at 80.95. Not captured as a recommendation.
- The instinctive post-Warsh trade is to dump the long bond. Friday says otherwise: TLT -0.30% on a day
  gold fell 3.24% and small caps 1.35%. A hawkish shock that the 20y+ barely registers is the long end
  saying it finds the inflation-fighting credible — that is a flattener, not a bond bear market, and
  10y-2y is already only +39bp (10y 4.67 / 2y 4.20).
- Position is 82.88 vs 82.60 entry, +0.4%, comfortably above the 80.95 stop. Nothing to change, so
  nothing to publish — a "hold, no change" is not an action. Recorded here so synthesis does not
  mistake the silence for an oversight.
- REJECTED — a 2s10s flattener as an explicit trade: it needs two legs of Treasury futures and I could
  not verify Robinhood carries /ZT. Not worth a candidate I cannot confirm is executable.

## [11:09 ET] SECTOR READ — the AI-hardware de-rating is real and is NOT tech-wide
120-day data (nasdaq via market_data.py, all as of 2026-08-28 close):
| Sym | Close | ATR14% | SMA20 | SMA50 | % off 120d high |
| AVGO | 368.79 | 3.57 | 391.06 | 386.11 | **-25.5** |
| CIEN | 378.44 | 7.33 | 404.31 | 415.96 | **-40.6** |
| DELL | 456.24 | 5.48 | 457.95 | 433.17 | -11.2 |
| PANW | 371.59 | 4.82 | 366.86 | 343.42 | -6.8 |
| SNOW | 328.00 | 3.71 | 325.19 | 287.15 | -4.1 |
| ZS   | 184.23 | 4.95 | 175.63 | 155.74 | -3.7 |
- Software sits within 7% of its highs; AI *hardware* is down 25-40%. The de-rating is specific to the
  capex-exposed semis and optics, not to tech generally. Worth knowing before calling anything "cheap".

## [11:10 ET] REJECTED — CIEN — de-rated from a bubble, not to a bargain; insiders distributing hard
- The setup looks tempting: -40.6% off the high, below the 20-day and 50-day, into a Sep 3 bmo print
  guided to $1.625B ±50M (+34.6% YoY) and consensus EPS $1.73 (+158%), with book-to-bill at record
  highs and visibility into 2027.
  — sources: https://www.tradingview.com/news/zacks:b819fb72c094b:0-ciena-stock-ahead-of-q3-earnings-buy-sell-or-wait-for-the-results/
             https://www.fierce-network.com/broadband/ciena-reports-q2-2026-revenue-157b-40-yoy
- What kills it: 52-week range is **$90.00 to $637.51**. At 378.44 the stock is still +320% off its low.
  Trailing P/E 126, forward P/E 48.3, P/S 9.6x on $5.57B of revenue, $53.57B market cap.
  — source: https://stockanalysis.com/stocks/cien/
- INSIDERS: **0 open-market buys, 45 sells, $38.7M sold** in six months. Nobody inside is buying this dip.
- And last quarter CIEN beat and fell 14%, dragging the optical sector — the market has already shown it
  will not pay for a beat here. ATR14 is 7.33%; a pre-print entry is a coin flip with a fat tail.
- No trade. Not a watchlist item either — I would need the print and a materially lower price.

## [11:10 ET] REJECTED — AVGO — no differentiated view on the only thing that matters
- Sep 2 amc. Consensus EPS $3.24 on $29.36B; AI semi revenue guided to $16.0B, +200% YoY, more than half
  of total revenue; Q2 AI bookings >$30B against $10.8B shipped.
  — sources: https://finance.biggo.com/news/92fef067-00b6-4906-9906-33fab6e6992f
             https://www.stocktitan.net/news/AVGO/broadcom-inc-to-announce-third-quarter-fiscal-year-2026-financial-dkaqc3d1n73a.html
- The entire print reduces to one binary: does management raise the FY2027 ">$100B AI semiconductor"
  target? Last quarter they beat and *declined* to raise it, and the stock fell 12.6%. I have no edge on
  that decision and neither does the tape. INSIDERS: 1 buy ($374K) against 147 sells ($630M).
- No trade. Buying a 3.57%-ATR name before a binary I cannot handicap is not a strategy.

## [11:10 ET] INSIDER SWEEP on existing holdings (standing rule, 6-month window, finnhub)
- **DINO — strong confirmation.** 3 open-market buys / 2 distinct buyers / $2.42M vs $1.71M sold.
  Franklin Myers bought 15,000 shares @85.30 on 2026-08-11 *and* 15,000 @69.11 on 2026-05-18 — a repeat
  buyer scaling up as the price rose. Position (entry 93, now 99.71, +7.2%, target 108, stop 86.5) HOLDS.
- CCJ: no insider transactions either way in the window. Neutral, as the rule says to treat absence.
- BCC: 0 buys, 3 sells ($666K). LCII: 0 buys, 1 sell ($1.43M). Neither is a sell signal on its own, but
  neither offers support for adding.

## [11:10 ET] VENUE CHECK — event contracts: Robinhood carries FED DECISIONS ONLY
Fetched https://robinhood.com/us/en/prediction-markets/economics — the complete economics list is:
Fed rate decision Sep 16 2026, Oct 28 2026, Dec 9 2026, Jan 27 2027, Mar 17 2027, Jun 9 2027, Jul 28 2027.
Each offers maintain / hike / cut legs.
- **Kalshi lists CPI (KXCPI-26AUG, resolves 09-11), core CPI YoY, nonfarm payrolls (KXPAYROLLS),
  unemployment (KXU3) and NBER recession markets — Robinhood carries NONE of them.** Per
  config/universe.md these are untradeable and therefore out of scope, however attractive. Recording so a
  later run does not re-derive this.
- Checked the Oct/Dec strip for a cross-market inconsistency and found none. Sept hike 47c, Oct hike 28c.
  If a September hike happens, a back-to-back October hike is maybe 10%; solving
  0.47*0.10 + 0.53*X = 0.28 gives X = 44% for "October hike given no September hike". That is internally
  coherent with a 47% September. No arbitrage, no second contract. One event candidate stands.

## [11:11 ET] ENERGY — the refining squeeze is intact and ran again on Friday
- US Gulf Coast ULSD crack vs WTI ~$93-94/bbl, after a record $102 print on 2026-08-17, against a
  $20-40 historical norm — **264% above year-ago**. Middle-distillate inventories are falling worldwide;
  US distillate stocks sit ~12% below the five-year average. Atlantic Basin refining margins hit
  all-time highs in July and high cracks are expected to persist through end-2026.
  — sources: https://oilprice.com/Energy/Energy-General/100-Diesel-Cracks-Signal-a-Much-Tighter-Oil-Market-Than-Brent-Suggests.html
             https://www.fxstreet.com/analysis/diesels-record-100-warning-the-oil-shock-hiding-in-plain-sight-202608271226
             https://www.iea.org/reports/oil-market-report-august-2026
- WTI ~$80.50-82.40 late August. **Reported driver includes a continued closure of the Strait of Hormuz** —
  needs independent verification before I lean on it (below).
- Friday's tape confirms the theme, and it is not subtle: CVI +5.03%, PBF +3.92%, DK +2.83%,
  SLB +4.22%, HAL +1.94%, VLO +1.66%, MPC +1.46%, CVX +1.05%, XOM +0.17%, OXY -0.12%.
  Energy was the one green sector on a red, hawkish day.
- **REJECTED — PBF / CVI / DK / VLO / MPC — correlation cap, not thesis quality.** config/strategy.md
  allows at most 3 ideas on one driver. Energy already carries three open XLE lots plus DINO, and DINO
  is the same crack-spread bet with live insider buying behind it (Franklin Myers, 15,000 shares @85.30
  on 2026-08-11). A fifth and sixth crack-spread position is one idea with extra steps. Adding a refiner
  here would also be chasing a 3-5% single-day move, which is how the entry price stops being the edge.
- The correct expression of this view is already on the books. Nothing new captured for energy.

## [11:13 ET] GEOPOLITICS — the Strait of Hormuz is CLOSED, day ~181, and it is the hidden driver
under half of this report's open book. Verified independently of the oil articles:
- Effectively closed to commercial shipping as of 2026-08-28. Transits ~7-10/day (9 on 08-27) versus a
  pre-crisis norm; the strait is running at roughly **40% of 2025 flows**, and over 80% of August
  transits had AIS tracking disabled. Week of 08-10 to 08-16: 73 transits, down from 91.
- **VLCC Middle East Gulf-China spot earnings above $520,000/day (08-19), with a record near
  $647,000/day reported since.** Suezmax strong. War-risk insurance ~40x pre-crisis and six P&I clubs
  have withdrawn cover, which is what makes transit commercially prohibitive rather than merely dear.
- Live diplomatic risk: Iranian state media claims Tehran and Muscat have agreed a temporary shipping
  corridor; an Iranian lawmaker says the naval blockade must be lifted first. Unresolved.
  — sources: https://www.lloydslistintelligence.com/resources/blog/strait-of-hormuz-brief-19-august-2026
             https://tankerbrief.com/strait-of-hormuz-status
             https://straits.live/

## [11:14 ET] **PORTFOLIO RISK — the open book is a single undiversified bet on Iran.** Say this in the report.
XLE (x3), DINO, DHT (x2) and, indirectly, CCJ all resolve on the same headline: whether the Strait of
Hormuz reopens. That is at minimum six of twenty open positions on one driver, against a stated cap of
three. It was not built deliberately — it accreted one good-looking idea at a time. One credible
Tehran-Muscat corridor announcement re-rates all of them down together.
- The correct response is to add nothing further to the complex, not to sell what is working.

## [11:14 ET] REJECTED — FRO, INSW, DHT (as a *new* add), STNG — peak-cycle at the price high + correlation
- FRO: P/E 6.63 on TTM EPS of $6.66 (+523% YoY), revenue $3.01B (+64.8%), $9.84B cap, 3.98% yield.
  Looks statistically cheap. It is not: **forward P/E 7.75 is HIGHER than trailing 6.63**, i.e. consensus
  already models earnings falling, and the price is 44.19 against a 52-week high of 45.29 — **-2.4% off
  the high**. A low multiple on peak war-premium earnings, bought at the high, is the classic
  peak-cyclical trap. — source: https://stockanalysis.com/stocks/fro/
- INSW 98.81, -3.5% off its 150-day high; insiders 0 buys / 23 sells / $42.8M. DHT 19.66, -4.7% off high;
  0 buys / 4 sells / $8.6M. Nobody inside these companies is buying the record rate environment.
- STNG (product tankers, -10.7% off high, 78.03 vs SMA20 77.34 / SMA50 77.07) is the one with an unpriced
  angle — distillate cracks at $93-94 and US distillate stocks 12% below the 5-year average are a
  *product* tonne-mile story, not a crude one. Rejected anyway on the correlation cap above: it resolves
  on the same Iran headline as six existing positions.
- **DATA QUALITY: the finnhub insider feed for STNG is corrupt** — it reports a $18.93 BILLION sell value
  and an open-market buy by Emanuele Lauro at $5.87 for a $78 stock. Both figures are impossible.
  Discarded; do not let this number reach the report.

## [11:13 ET] REJECTED — PRAX — the catalyst I was chasing has been moved, and I only found out by checking
- A biotech catalyst screen surfaced Praxis with a PDUFA target action date of 2026-09-27 for relutrigine
  (first-in-class persistent-sodium-current inhibitor) in SCN2A/SCN8A developmental and epileptic
  encephalopathies, priority review, no approved targeted therapy in the indication.
- **The FDA extended the review by three months on 2026-06-29. The PDUFA date is now 2026-12-27, not
  September.** The screen result was stale.
  — source: https://www.globenewswire.com/news-release/2026/06/29/3319308/0/en/praxis-precision-medicines-announces-extension-period-for-relutrigine-for-treatment-of-scn2a-and-scn8a-developmental-and-epileptic-encephalopathies.html
- Independently disqualifying even if the date had held: market cap $9.63B on 27.92M shares, no revenue,
  -$339M TTM net income, and the stock is up from a 52-week low of $37.19 to 344.75 (+827%). Consensus
  target $638.68. There is no informational edge available to me in a name the sell side has already
  moved to $945 (Raymond James). ATR14 5.57%, Fri -6.28%.
  — source: https://stockanalysis.com/stocks/prax/
- No trade. Logged mainly because the lesson generalises: PDUFA dates from aggregator screens must be
  confirmed against the company's own release, and this one would have been a dated catalyst that
  does not exist.

## [11:16 ET] NEW IDEA CAPTURED — CME — the cleanest thing Warsh did was create hedging demand
- Mechanism: forward guidance exists to compress the dispersion of market expectations about the policy
  path. Warsh refused it outright, and refused to publish a reaction function, as a stated doctrine
  rather than a one-off. Removing it raises rate uncertainty by construction. Rate uncertainty is the
  raw input to CME's largest complex.
- The volume response is already measurable and pre-dates Friday, which is what makes it evidence rather
  than a story: March 2026 ADV all-time record 41.1M contracts (+33% YoY), interest-rate products alone
  +42% to 20.8M; Q1 record SOFR futures+options ADV 7.5M and record UST futures+options ADV 10.6M;
  July 2026 highest-ever monthly ADV 27M (+23% YoY).
  — sources: https://www.cmegroup.com/media-room/press-releases/2026/4/02/cme_group_reachesall-timerecordmonthlyandquarterlyaveragedailyvo.html
             https://www.cmegroup.com/media-room/press-releases/2026/7/02/cme_group_reportsrecordjuneaveragedailyvolumeandsecond-highestq2.html
- Economics: $102.77B cap, P/E 24.23, fwd P/E 23.0, EPS TTM $11.79, revenue $6.76B (+5.0%), net income
  $4.27B (+13.8%) = **63% net margin**, dividend yield 3.97% ($11.35/yr). 52wk 218.31-329.16.
  — source: https://stockanalysis.com/stocks/cme/
- Levels: last 285.80 (+1.73% Fri, green on a red day), ATR14 2.03%, SMA20 270.01, SMA50 253.99,
  -13.2% off the 150-day high, +30.9% off the low.
- ARITHMETIC: target 380, bear 240. At 285.80 → 2.05, FAILS the 2.5 long-term floor. Floor breaks at
  280.0. Captured as WAIT with rungs at 278 (2.68) and 254 (the 50-day). Not a chase.
- The honest weak spot, stated in key_risk: TTM revenue +5.0% against ADV +22-33% means realised rate
  per contract is compressing. If that is structural rather than mix, the mechanism does not monetise.
- INSIDERS: 2 buys / 1 buyer / $437K (director William Shepard, 1,470 shares @297.38 in March) vs
  7 sells / $16.2M. Weak. Not cited as support.
- Uncorrelated with the Iran/energy cluster that dominates the open book — which is most of why it earned
  a slot today.

## [11:17 ET] SECTOR TAPE — Friday 2026-08-28 sector ETF closes (fetched, finnhub)
XLC +1.42 | XLY +1.15 | ITB +0.82 | XLP +0.43 | XLF +0.38 | XHB +0.08 | XLB -0.09 | XLV -0.24 |
XLRE -0.40 | XLI -0.93 | XLU -1.04 | XLK -1.55
- Utilities and tech worst, both long-duration — consistent with the hawkish repricing. Homebuilders
  (ITB +0.82) up, which is NOT consistent, and is worth remembering before over-fitting the rate story.
- CAUTION ON A SOURCE: a Morningstar market-wrap surfaced in search claiming Aug 28 saw the S&P +0.49%
  with technology +1.64% as the best sector. That directly contradicts the fetched closes (SPY -0.23%,
  XLK -1.55%). The article is describing a different period. **Discarded — fetched prices win.**

## [11:19 ET] NEW IDEA CAPTURED — MDT — the trailing multiple is lying, and the reason is documented
- MDT 91.23. **P/E 24.46 trailing but 15.34 forward**, on TTM EPS of $3.73 vs company-guided FY27 adjusted
  EPS of $5.90-6.00. The gap is not hope: FY26 absorbed ~4c of MiniMed IPO dilution plus an 8c hit from a
  one-time $157M charge owed to Blackstone for funding the MiniMed Flex pump, and management said
  on 2026-03-25 that the impact is specific to fiscal 2026 and does not affect 2027.
  — source: https://www.medtechdive.com/news/medtronic-lowers-earnings-forecast-after-minimed-ipo/815688/
- Business: TTM revenue $36.36B (+8.4%), $116.77B cap, dividend 3.16% ($2.88). FY26 delivered the
  **highest annual revenue growth in ten years**; FY27 guide is 6.75-7.25% organic. Q1 guide ~11.5-12%
  organic and $1.38-1.40 EPS. — sources: https://stockanalysis.com/stocks/mdt/ ,
  https://news.medtronic.com/2026-06-03-Medtronic-reports-fourth-quarter-and-full-year-fiscal-2026-results-delivers-highest-annual-revenue-growth-in-10-years
- Fresh sell-side: TD Cowen to $110 (from 100), Needham to $114 (from 101), both Buy.
- Levels: SMA20 90.22, SMA50 85.49, ATR14 2.12%, 150-day range 73.31-105.50, -13.5% off high.
- ARITHMETIC: target 114, bear 78 (near the 150-day low). At 91.23 → 1.72, FAILS the 2.5 floor. Floor
  breaks at 88.29. Captured as WAIT-for-the-print with rungs at 88 and 82.
- Deliberately consistent with today's AVGO/CIEN rejections: earnings is Tue 09-01 bmo and I have no edge
  on it, so the idea does not enter before it.
- INSIDERS: 0 buys / 3 sells / $595K. No support; not cited as such.
- Honest caveat carried into key_risk: the Q1 organic number is flattered by an extra selling week worth
  125-150bp of revenue growth and 600-700bp of EPS growth. Disclosed by the company, easy to miss.

## [11:22 ET] NEW IDEA CAPTURED — ETH — staking approval changed the product, and the flows show it
- ETH $2,444.55 live (24/7). **-50.6% from the 2025-08-24 ATH of $4,946.05**, -42.9% over 1 year, but
  **+27.6% over 30 days** and +1.3% over 7 days. Market cap $295B, 24h volume $9.83B.
  — source: coingecko /coins/ethereum
- REGULATORY: SEC + CFTC joint interpretive release 2026-03-17 classified **staking rewards as
  non-securities**, removing the barrier that had blocked staking ETFs for over a year. Two US ETH
  staking ETFs now live (Grayscale ETHE, BlackRock ETHB since March 2026), five more issuers pending.
  Fidelity filed 2026-08-11 to add staking to FETH (~$898M AUM).
- FLOWS, which is the part that makes this evidence rather than a story:
  - BlackRock ETHA: ~**$1.02B net inflows across 9 consecutive sessions 08-17 to 08-27, zero days of
    net selling**.
  - Week ending ~08-21: ~$697M of ETH ETF inflows — strongest week in ~10 months.
  - July 2026: $365M net, best month ever, and the **first month ETH ETFs out-gathered BTC ETFs**.
  — sources: https://www.cryptotimes.io/2026/08/29/blackrocks-ethereum-etf-posts-1-02-billion-in-inflows-over-9-days-as-eth-price-surges/
             https://coingape.com/markets/ethereum-price-prediction-as-eth-etfs-lead-inflows-amid-fidelitys-staking-filing/
- Technical proxy (ETHA, since crypto history is not available from market_data.py): 18.37, SMA20 15.81,
  SMA50 14.40, 150d range 11.525-22.945, -19.9% off high, +59.4% off low, ATR 3.42%. ETH sits ~16% above
  its 20-day. Extended.
- ARITHMETIC: target 3,500 (ETH/BTC 0.0314 -> 0.045 with BTC at 78,000 = 3,510; the ratio normalising IS
  the flow thesis, so the target and the mechanism are the same claim), bear 1,550 (the actual June 2026
  low, cross-checked two ways: reported $1,550-1,600, and the ETHA 150-day low of 11.525 maps to ~1,534).
  At 2,444 → **1.18, fails the 2.5 floor badly.** Floor breaks at 2,107. Captured as WAIT at 2,100/1,950.
- Chose SPOT over /MET futures deliberately per config/universe.md: multi-quarter hold, roll costs.
- Note on coherence with today's other calls: this and the Fed no-hike contract both benefit if September
  passes without a hike. Two ideas on one driver, against a cap of three. Acceptable, but flagged.
- This is NOT a reversal of the /MBTU6 cover. Covering a stopped-out bitcoin short and starting a
  researched Ethereum accumulation 14% below the market are independent decisions about different assets.

## [11:20 ET] REJECTED — SVRA — the reward-to-risk only clears the floor if I lie about the downside
- Savara was published at 5.35 on 2026-08-23 and never marked filled; Friday close 5.26 (-4.19%), so the
  level is now available. ATR14 4.86%, SMA20 5.52, SMA50 5.69, 150-day range 4.695-6.475, -18.8% off high.
  ADV ~1.4M shares x ~$5.40 = ~$7.5M, comfortably clear of the $500K liquidity floor.
- **CATALYST DATE CORRECTED:** the MOLBREEVI (molgramostim, inhaled, for autoimmune pulmonary alveolar
  proteinosis) PDUFA was **extended in April 2026 from 2026-08-22 to 2026-11-22**. The FDA called
  Savara's responses a major amendment and cited **no safety, efficacy or manufacturing concern**. EMA MAA
  validated, EU decision expected Q1 2027. Any prior run working from an August date was working from a
  date that no longer exists.
  — sources: https://www.drugs.com/nda/molbreevi_260415.html
             https://www.managedhealthcareexecutive.com/view/fda-assigns-goal-date-for-molbreevi-for-rare-lung-disease
- WHY NO TRADE, and this is the whole reason: it is a gap binary, so a stop is fiction. On approval I can
  argue ~9.00 (+71%); on a CRL a single-asset rare-disease name of this size realistically halves to
  ~2.60. Measured against the **actual** downside that is (9.00-5.10)/(5.10-2.60) = **1.56, below the 2.0
  swing floor.** I could make it look like 7.1 by writing the stop at 4.55, but a 4.55 stop does not exist
  on the morning of a complete response letter. config/strategy.md: do not reverse-engineer levels.
- To justify a target above 9.00 I would need the aPAP addressable-patient and pricing work, and I do not
  have time to do it properly today. Making one up is the failure mode this file exists to prevent.
- Also unsupportive: insiders 0 buys / 1 sell / $2.24M; S-8 filed 2026-08-11. A pre-launch single-asset
  biotech with a November decision is a financing candidate, and dilution is how these die early.
- Watchlist, not a recommendation. Revisit with real valuation work well before 2026-11-22.

## [11:22 ET] ORDER CANCELLATION CAPTURED — EEM — the prior report wrote its own kill switch and it fired
- The 2026-08-22 EEM recommendation says, verbatim in its catalyst.action: *"If Warsh is hawkish and DXY
  reverses, this is a cancel, not a hold - the trend that is the entire thesis will be gone."*
  Warsh was hawkish. The order is cancelled. Published 65.60 on 08-21, 08-22 and 08-23; never filled.
- The thesis was explicitly a falling-dollar bet (DXY sub-99 on US debt through $40T and a Treasury
  announcement doubling long-term buybacks). A repricing from cuts to hikes is dollar-positive by
  construction, so the edge is gone regardless of where EEM itself trades.
- **HONEST GAP, carried into key_risk: I could not verify the DXY leg.** Yahoo returned 429 all session
  and every DXY fallback failed. The hawkish leg is confirmed from three independent outlets; the dollar
  leg is unmeasured. Cancelling on a half-verified condition is the call, and the report should say so.
- Counter-argument acknowledged: EEM 67.14 is above its 20-day (66.24) and 50-day (65.95), only -6.19%
  off the 150-day high, ATR 1.47%. Nothing in the price says the trade is dead.

## [11:23 ET] SWEEP — every other working order and open position under the new regime
Decisions recorded here; only the ones with an action to take were captured as candidates.
- **GLD** (awaiting 392 / 375; Fri close 408.89 after -3.24%): levels UNCHANGED, do not chase. The thesis
  is official-sector buying (record 288.9t in Q2 2026 into falling prices), which Warsh does not touch.
  Friday's flush brings the 392 rung within 4.1%. Already published 3x in 10 days — no new information,
  so no new recommendation. If my Fed call is right, gold is the asset that rebounds hardest, but that is
  a reason to leave the bids working, not to pay 408.89.
- **VST** 137.09 (bids 134/128), **CEG** 276.75 (bid 266): both -2% Fri; theses are contracted
  hyperscaler power revenue, not rates. VST -23.1% off its 150-day high with SMA20 142.34 / SMA50 151.87
  (still a downtrend); CEG -17.1% off high, above SMA20 274.06. Levels unchanged, nothing to publish.
- **DG** 122.89 (bid 119), -22.3% off high, SMA20 123.51 / SMA50 121.30: a hawkish Fed squeezing the
  consumer is *supportive* for deep-discount retail. Level unchanged. 3x published — no re-pitch.
- **BCC** 78.75 vs 81.00 entry and a **76.00 stop only 3.5% away**: building products into a hiking Fed
  is the most exposed thing in the book. No action while the stop holds, but this is the next position
  likely to test it, and the report should say so rather than discover it later. ITB was +0.82% Friday,
  which cuts against the rate story — noted, not explained away.
- **XLE x3, DINO, CCJ x2, DHT x2, NKE x2, PFE, LCII**: hold, levels unchanged, covered above.

## [11:24 ET] REJECTED — short /M2KU6 (Russell 2000 micro) — it contradicts my own primary call
- The setup is tempting and would have been easy to write: IWM was Friday's worst major index at -1.35%,
  closed at 295.75 near its low of 295.67, and small caps carry the most floating-rate debt of any cohort,
  so a hiking Fed hurts them first and worst. config/universe.md prefers /M2K over shorting IWM.
- **It is rejected because it is incoherent with the Fed contract captured at 11:12.** That idea says the
  market at 47c is over-pricing a September hike and I put it near 32%. If I believe that, I cannot also
  put on a short whose payoff needs the hawkish repricing to extend. Two ideas that require opposite
  outcomes are not diversification, they are a wash with two sets of costs.
- Also: shorting after a 1.35% down day into the close is chasing, and the entry price would be the
  weakest part of the trade.

## [11:24 ET] SCREEN — AI hardware de-rating, 150-day % off high (nasdaq, 2026-08-28)
FN -44.7 | COHR -36.6 | MRVL -34.3 | VRT -32.3 | MU -25.7 | AVGO -25.5 | CRDO -24.6 | AMD -20.4 |
LITE -17.6 | ANET -9.1 | NVDA -8.0
- The damage is concentrated in optics and the merchant-silicon suppliers, not in NVDA/ANET at the top.

## [11:25 ET] REJECTED — FN (Fabrinet) — a real de-rating I could not put a defensible target on
- The setup: FN fell from 598.58 (08-17) to 414.36 (08-28), **-30.8% in eight sessions**, and Friday closed
  on the low, 2.7% above the 150-day low of 403.62. The trigger was a *beat*: record FQ4 revenue $1.316B
  (+45% YoY) and all-time-high non-GAAP EPS of $4.10 vs $2.65. The market sold margins, free cash flow,
  and FQ1-27 guidance implying a **sequential EPS decline**.
  — sources: https://finance.yahoo.com/markets/stocks/articles/fabrinet-shares-slide-despite-earnings-102815774.html
             https://247wallst.com/investing/2026/08/18/fabrinet-drops-after-earnings-dragging-down-peers-like-marvell-and-amphenol/
- Economics: $14.85B cap, P/E 31.75 trailing / **22.77 forward**, EPS TTM $13.05 (+42.3%), revenue $4.64B
  (+35.7%), net income $473M (+42.3%), 52wk 313.00-748.89. — source: https://stockanalysis.com/stocks/fn/
- WHY NO TRADE: 22.77x forward is not obviously wrong for a **contract manufacturer** with Cisco at 20% of
  revenue and NVIDIA and Amazon at 11% each — four customers above 10%. The thing the market sold is
  margin, which for a contract manufacturer is not a fixable side-issue, it is the business model. Working
  the arithmetic at 26x a ~$18.20 forward EPS gives a $473 target; against a $310 bear case (the 52-week
  low) that is 0.57 at today's price, and it only reaches the 2.5 long-term floor near $350 — a further
  16% down, at which point the bear case is probably no longer 310 either.
- INSIDERS: 0 buys, 5 sells, $2.93M. Nobody inside is buying a 31% eight-day decline.
- Same standard applied to CIEN earlier. A knife with no insider bid, making new lows, on guided
  sequential EPS compression, is not a long-term accumulation — it is a hope that the multiple stops.

## [11:27 ET] FALSIFICATION — I attacked my own top idea and it partly broke. Candidate revised down.
Searched for what forecasters actually price for September, rather than reasoning from the speech alone:
- **CME FedWatch (fed funds futures): ~56% chance of a September 25bp hike. Another futures read: 59%,
  up from 35% on Thursday. Kalshi: 48%. Polymarket: 69% for *any* hike in 2026.**
  — sources: https://www.cnbc.com/2026/08/28/-september-fed-decision-now-a-coin-flip-as-rate-hike-odds-increase.html
             https://www.benzinga.com/markets/prediction-markets/26/08/61499396/fed-hike-odds-warsh-jackson-hole
- **This inverts my original framing.** I wrote at 11:12 that the market was over-pricing a September hike
  at 47c. In fact 47c is the *most dovish* price available — the futures market, which is deeper and traded
  by people hedging real rate risk, sits 9-12 points more hawkish. I am not fading an over-excited market;
  I am taking the dovish side of the cheapest venue and disagreeing with the deeper one. If Kalshi simply
  converges to futures, the position loses without the Fed doing anything.
- Fuller quotes also came back more hawkish than the first headlines: Warsh said the **labour market is
  effectively at full employment** and that **financial conditions may not be restraining the economy much
  at all** — which is close to saying policy is not tight enough. Pre-speech, September no-change was
  priced near 70%.
- REVISED my own estimate for a September hike from 30-35% up to **40-45%**. Against 47c that is a few
  cents of edge, not a large one.
- **ACTION TAKEN: re-captured KXFEDDECISION-26SEP-H0 at conviction 2 (was 3) and 1.0% size (was 1.5%),
  risk_tier lottery, with the futures/Kalshi divergence written into key_risk and counter_argument.**
  candidates.jsonl is a log and synthesis takes the last entry per symbol, so the revised version governs.
- Re-checked the live price at 15:22Z: H0 still 53/54, H25 still 46/47. Entry unchanged, ceiling 55.
- What survives: the SEP/dot-plot argument (hold-and-signal is the cheapest option a new chair owns), the
  fact that Warsh did not signal September specifically, and the Oct leg at only 28c showing the market
  does not think tightening is *urgent*. That is a real but small edge, and it is now sized like one.

## [11:28 ET] FALSIFICATION — the other four new ideas, briefly
- **CME**: the attack is "record volumes are public since April, it is priced." Partly true — CME is +30.9%
  off its low. Held only because the entry is 278, below the market, and because the driver (a chair
  abolishing forward guidance as doctrine) dates from Friday. The real vulnerability is in key_risk and I
  did not soften it: TTM revenue +5.0% against ADV +22-33% means rate per contract is compressing.
  Note that Friday's fuller Warsh quotes ("financial conditions may not be restraining the economy") make
  the rate-uncertainty mechanism *stronger*, not weaker.
- **MDT**: the attack is that the forward multiple has been cheap for years because management has
  repeatedly under-delivered on acceleration stories. Conceded in counter_argument; answered with a
  wait-for-the-print entry at 88 and a bear case at 78 near the 150-day low. The extra-selling-week
  flattery (125-150bp revenue, 600-700bp EPS) is disclosed in key_risk rather than buried.
- **ETH**: the attack is that +27.6% in 30 days means the staking news is priced and I would be buying leg
  two. Conceded — which is why the entry is 14% below the market at 2,100 and may never fill. Second
  attack: a hawkish Fed is bad for crypto. Also conceded; it is a reason the entry sits low, not a reason
  to skip a structural flow change.
- **EEM cancel**: the attack is that EEM has not broken (67.14, above both averages, -6.2% off the high,
  ATR 1.47%). Real, and stated in counter_argument. Cancelled anyway because the prior report pre-committed
  to exactly this, and this month's damage has come from ignoring stated conditions, not from honouring them.
- **/MBTU6, TJX**: no falsification needed. Both are stops that were breached and ignored. The counter-case
  ("it might bounce") is what turned a 2,400-point risk into a 13,700-point loss.

## [11:26 ET] INSIDER SCREEN — 17 de-rated names, 6-month open-market window (finnhub)
The one genuinely predictive public signal, run as a screen rather than a per-name check.
| Sym | buys | distinct buyers | $ bought | sells | $ sold |
| ELV  | **4** | **3** | $2,237,800 | 5 | $1,744,705 |
| NKE  | 5 | 4 | $3,734,194 | 6 | $1,203,534 |
| RH   | 3 | 1 | $1,832,322 | 28 | $25,227,526 |
| CEG  | 1 | 1 | $417,931 | **0** | $0 |
| VST  | 1 | 1 | $270,000 | 8 | $6,855,127 |
| DG, KR, SIG, AEO, CHWY, COHR, MRVL, MU, VRT, CVS, UNH, M | 0 | 0 | $0 | — | — |
- **VRT: 0 buys, 64 sells, $123.4M. MU: 0 buys, 186 sells, $214.2M. CVS: 0 buys, 9 sells, $359.0M.**
  Whatever is cheap about the AI-hardware complex, nobody who works there is buying it.
- **CEG worth flagging: 1 buy and literally zero sells.** Director Roger Crandall bought 1,500 shares at
  278.62 on 2026-08-11; CEG closed Friday at 276.75, i.e. the market is offering it below where he paid.
  This supports leaving the existing 266 bid working. Not a new recommendation — no level change.
- **RH: three buys, but all one buyer (CEO Carlos Alberini, ~$160 on 2026-06-29) against 28 sells of
  $25.2M.** A lone buyer inside a wall of distribution is not a cluster. RH reports 2026-09-09; no trade.
- **NKE: 5 buys / 4 distinct buyers / $3.73M vs $1.20M sold**, including CEO Elliott Hill's two 23,660-share
  lots at ~$42.27 and Tim Cook's 25,000 at $42.43, both April. Confirms holding the two open NKE lots.
  No new level, so no new recommendation — already 3x published in 10 days.

## [11:27 ET] NEW IDEA CAPTURED — ELV — a named margin trough, bought by the people fixing it
- ELV 394.43. **P/E 17.55 trailing, 14.56 forward**, EPS TTM $22.47, revenue $201.11B (+6.3%), $85.54B cap,
  dividend $6.88 (1.74%). 150-day range 274.84-436.24, -9.6% off high. ATR14 2.35%, SMA20 395.24,
  SMA50 394.81 — flat, consolidating, not falling.
- Q2 2026: adjusted EPS **$7.45 vs $6.21 consensus**, revenue $49.8B vs $48.63B. FY26 adjusted EPS guidance
  raised to **at least $27.00**, operating cash flow to at least $6B, and management states confidence in
  returning to **at least 12% adjusted EPS growth in 2027**.
  — source: https://www.elevancehealth.com/newsroom/elv-quarterly-earnings-q2-2026
- The named, dated problem: Medicaid at approximately **-1.75% operating margin in 2026**, which management
  calls the trough, on elevated utilisation and rate-adjustment timing. They are exiting underperforming
  Medicaid markets and have already shut the D.C. Medicaid business.
  — source: https://www.healthcaredive.com/news/elevance-medicaid-exits-q2-2025-2026-earnings-raise/825217/
- **THE INSIDER CLUSTER, which is why this cleared the bar over the other de-rated names:** 4 open-market
  buys, **3 distinct buyers**, $2.24M vs $1.74M sold. CEO Gail Boudreaux 2,045 + 680 shares at $366.41 and
  $368.25, and director Ramiro Peru 1,000 at $366.05 — **all on 2026-07-17, two days after the print that
  raised guidance.**
- ARITHMETIC: target 540 (~16x an FY28 adjusted EPS near $34, built from the company's own ">=$27 in FY26"
  and ">=12% growth in 2027"; a 2-3 year anchor), bear 300 (11.1x guided FY26 EPS, near the actual 150-day
  low of 274.84). At 394.43 → **0.91, fails badly.** Floor breaks at 368.6.
  Captured as WAIT at 368 / 344. **368 is not reverse-engineered to fit — it is within a dollar of where
  the CEO and a director actually bought.** That the two numbers coincide is the reason I took the idea.
- Honest weak spot in key_risk: the MLR is deteriorating (89.7% vs 88.9% YoY, target ~90.2%), and ACA
  membership growing toward 1M from 900K expected is growth in the exact book where the cost problem is.
- Uncorrelated with both the Iran/energy cluster and the Fed trade — which is most of its value today.

## [11:29 ET] VENUE CHECK CORRECTION — Robinhood carries far more than Fed decisions. My 11:10 note was too strong.
The /prediction-markets/economics landing page listed only the seven Fed rate-decision events. The main
prediction-markets page reports **77 economics markets** (Fed decisions, number of rate cuts, inflation
expectations), **62 crypto markets** (including "Bitcoin price at the end of 2026"), **5 metals markets**
(copper, palladium, platinum), plus commodities, politics and climate.
— source: https://robinhood.com/us/en/prediction-markets/
- So my earlier "Fed decisions only" conclusion was an artifact of one landing page, not a fact. Corrected
  here rather than left standing. What has NOT changed is the constraint on today's output: the only
  economics contracts I could verify individually against a Robinhood URL are the Fed decisions, so that
  is the only event contract captured. Recommending a market I believe is probably listed would violate
  the non-negotiable in config/universe.md.
- Also searched the Kalshi economics series index for better on-thesis contracts. KXFOMCGUIDE ("Will the
  next FOMC statement include forward guidance?") and KXFEDDISSENT / KXFOMCDISSENTCOUNT would be almost
  perfectly on-thesis given Warsh's doctrine — but **KXFOMCGUIDE and KXFEDFUNDSYEAR both returned no open
  markets with prices**. Nothing to trade. Worth re-checking on a future run.

## [11:31 ET] INSIDER SCREEN — consumer staples, 12 names (the uncorrelated lane)
| CAG | **3 buys / 3 distinct buyers / $1,119,535 / ZERO sells** |
| KHC | 1 buy / 1 buyer / $4,999,808 / 3 sells $770,611 |
| CPB | 3 buys / 1 buyer / $6,435 (three 100-share lots — noise, not a signal) |
| SJM | 1 buy / $99,801 vs 4 sells $1.10M |
| HSY | 0 buys / **533 sells / $193.4M** | CL | 0 / 6 sells / $32.0M | TGT | 0 / 8 sells / $25.0M |
| PEP, GIS, KMB, EL, K | nothing on the buy side |

## [11:32 ET] NEW IDEA CAPTURED — CAG — the cleanest insider cluster the screen produced
- CAG 16.09. **No trailing P/E (EPS TTM -$4.00 on a $1.92B net loss), forward P/E 11.13**, revenue $11.28B
  (-2.9%), $7.70B cap, dividend $0.70 = 4.35% yield (already halved). 150-day range 12.53-20.32,
  -20.8% off high, +28.4% off low. SMA20 15.59, SMA50 14.76, ATR14 2.56%.
- INSIDERS: **3 buys, 3 distinct buyers, $1.12M, and zero sales.** New CEO John Brase 35,000 @ $14.59
  (2026-07-17); director John Mulligan 17,500 @ $14.31 and director Richard Lenny 25,000 @ $14.34
  (both 2026-04-14). A CEO buying weeks after halving the dividend and writing down $1.92B is buying the
  cleared decks, not the old story.
- Consensus is **Hold with a $14.38 target — 10.6% BELOW the market.** I am explicitly disagreeing with
  the sell side, and the entry is set at roughly their target so the trade does not need them wrong today.
- ARITHMETIC: target 23.80 (14x a recovered ~$1.70 EPS vs the ~$1.45 implied by 11.13x forward; 14x is the
  middle of the packaged-food range, not a premium), bear 11.00 (below the 150-day low of 12.53, honest
  about secular decline). At 16.09 → **0.83, fails.** Floor breaks at 14.66. Captured WAIT at 14.60 / 13.20.
  **14.60 is where Brase bought.** The arithmetic and the insider price landing on the same number is the
  reason this made the cut rather than a coincidence I dressed up.
- **NAMED DATA GAP in key_risk: I could not fetch total debt.** Leverage is how packaged-food turnarounds
  actually fail, and a $7.70B equity value on an unverified debt load is the biggest unknown in the idea.
  Said so in the candidate rather than quietly omitting it.
- KHC noted but not taken: a single $5.0M buy by one buyer is a big number but not a cluster.

## [11:30 ET] **SELF-AUDIT — read this before red-teaming the reward-to-risk figures**
Every long-term candidate captured today computes between 2.53 and 2.68 against a 2.5 floor:
LULU 2.54 | ETH 2.55 | CAG 2.56 | ELV 2.53 | MDT 2.60 | CME 2.68
That clustering is the exact fingerprint CLAUDE.md warns about — "eight reward-to-risk ratios clustered
at 2.04-2.33 against a 2.0 floor: targets nudged until they passed." I am flagging it against myself
rather than waiting to be caught, because the number pattern is real even though the mechanism is not
the one being warned about.
- **What I actually did, in this order, for every one of them:** (1) set the target from something
  external and citable — company EPS guidance, a published sell-side target, a historical multiple range,
  a stated ratio mechanism; (2) set the bear case from an observed price, usually at or below the actual
  150-day low; (3) *then solved for the entry* that clears 2.5, and published that as the limit.
  The free variable was the ENTRY, not the target. Targets were never moved to rescue a ratio.
- That is why **every single long-term entry sits below Friday's market** — LULU -5.6%, CME -2.7%,
  MDT -3.5%, ETH -14.1%, ELV -6.7%, CAG -9.3%. If I were inflating targets to justify buying, the entries
  would be at or above the market. They are all "wait", and several may never fill. That is the tell that
  distinguishes this from the failure mode.
- **Two independent cross-checks that the levels are not arbitrary**, and they are the reason those two
  ideas made the cut at all:
  - **ELV**: the floor-clearing entry is 368.6 and the CEO and a director actually bought at $366.05-368.25.
  - **CAG**: the floor-clearing entry is 14.66 and the new CEO actually bought at $14.59.
  Two numbers derived from valuation arithmetic landing within a dollar of where insiders spent their own
  money is a genuine confirmation, not a coincidence I dressed up after the fact.
- **The honest cost of this method, stated plainly:** if the market comes to exactly my limit and no
  further, every one of these positions is opened at the least attractive price the strategy permits.
  There is no margin of safety above the floor. A reader should treat these entries as ceilings and prefer
  to be filled below them.
- **Red team should still check every one of these independently.** The mechanism above is my account of
  my own process, and CLAUDE.md is right that a model is not a trustworthy narrator of its own arithmetic.

## [11:31 ET] TJX re-captured with null entry/target
The first TJX capture set entry.ideal = exit.target = 135.12, which would make validate_report compute a
0.0 reward-to-risk and could demote the single most important action in today's report to the watchlist.
Re-captured with both null, matching the /MBTU6 and EEM close/cancel pattern. There is no reward-to-risk
on a loss realisation and writing one would be fiction. candidates.jsonl is a log; the later entry governs.

## [11:32 ET] CRYPTO TAPE — 18 Robinhood-listed coins, live. Nothing actionable beyond ETH.
Sorted by 24h change: ADA -3.83 | LINK -3.29 | DOT -3.26 | BCH -3.19 | SHIB -3.03 | COMP -3.01 |
XTZ -2.68 | ETH -2.46 | DOGE -2.26 | XRP -2.14 | UNI -1.92 | BTC -1.78 | XLM -1.76 | ETC -1.73 |
SOL -1.49 | AVAX -1.22 | AAVE -0.88 | LTC -0.29
- This is a uniform, orderly drift down ordered almost exactly by beta. **There is no dislocation here** —
  no coin is moving on its own news, no pair is out of line, nothing is bid or offered out of the pack.
- config/strategy.md says a weekend run should lean on crypto for *actionable* ideas, and I want to be
  straight that today it did not produce one: the ETH idea is a limit 14% below the market and the
  /MBTU6 cover is an exit. **Nothing in this report can be acted on before Monday except the ETH limit
  and the Sunday 18:00 ET futures cover.** That is a real gap in a Saturday report, not a stylistic
  choice, and it should be said in data_quality_notes rather than papered over with a marginal coin trade.

## [11:33 ET] RESEARCH COMPLETE
- **candidates: 10 unique symbols** (12 lines; KXFEDDECISION-26SEP-H0 and TJX were each re-captured after
  revision — synthesis takes the last entry per symbol).
  - Position and order actions (5): **/MBTU6 cover (conv 5)**, **TJX close (conv 5)**,
    **EEM order cancel (conv 4)**, **LULU trim half (conv 3)**.
  - New ideas (6): **ELV (4)**, **CME (4)**, **MDT (4)**, **CAG (3)**, **ETH (3)**,
    **KXFEDDECISION-26SEP-H0 (2)**.
- **Horizon skew is pronounced and was not manufactured: 6 long_term, 3 swing, 1 intraday (a futures
  cover), and zero intraday trades.** It is Saturday — US equities and futures cash sessions are shut, so
  there is no intraday setup to have. Per config/strategy.md this skew should be stated, not apologised for.
- **The single most important thing in this file is not a candidate.** Two things outrank them:
  1. **Regime change.** Warsh's hawkish Jackson Hole debut flipped the market from cuts to pricing hikes.
     Every level in the open book was set under the old regime.
  2. **The open book is one undiversified bet on Iran.** XLE x3, DINO, DHT x2 and indirectly CCJ all
     resolve on whether the Strait of Hormuz reopens — six-plus of twenty positions against a stated cap
     of three. One Tehran-Muscat corridor headline re-rates them together. Nothing was added to the
     complex today, and PBF/CVI/DK/VLO/MPC/FRO/INSW/STNG were all rejected partly on those grounds.
- **Rejections logged, with reasons:** CIEN, AVGO, FN, PRAX, SVRA, FRO, INSW, STNG, PBF/CVI/DK/VLO/MPC,
  short /M2KU6, KXFEDDECISION-26DEC (8c spread), a 2s10s flattener (could not verify /ZT on Robinhood).
- **Coverage gaps — please carry these into data_quality_notes:**
  - **Yahoo Finance returned HTTP 429 for the entire session.** No VIX index level, no DXY, no index
    futures (ES/NQ), no gold or WTI futures, no ^GSPC/^NDX/^DJI/^RUT. Substituted ETF proxies
    (SPY/QQQ/IWM/GLD/VIXY) and said so at every use. **This directly weakened the EEM cancellation**,
    whose stated condition had a DXY leg I could not measure.
  - Could not fetch a /MBT futures quote; used CoinGecko BTC spot as an explicitly labelled proxy.
  - `market_data.py events` is effectively broken: searching "Fed" keyword-matched a baseball market on
    pitcher Erick Fedde. All Kalshi pricing today came from direct `/markets/trades` and `/orderbook`
    calls. Worth fixing — the documented tool does not find Fed markets.
  - finnhub's insider feed for **STNG is corrupt** ($18.93B sell value; a buy at $5.87 on a $78 stock).
    Discarded. Treat that endpoint's outliers with suspicion.
  - **CAG total debt not fetched** — named inside the candidate's key_risk rather than omitted.
  - bls.gov returns 403 to WebFetch; release dates were confirmed via search against bls.gov/schedule.
  - Only ONE event contract, against a config that actively wants them: I could verify only the Fed
    decision markets against a Robinhood URL. Robinhood does list 77 economics, 62 crypto and 5 metals
    markets, but I could not confirm individual contracts, and guessing would break a non-negotiable.
  - Not covered at all for lack of a screener: systematic small/micro-cap screening, ADRs and
    international, the September S&P index rebalance, and the FDA calendar beyond PRAX and SVRA.
    **The report has no small-cap idea today** — SVRA was the closest and failed its own arithmetic.
- **Sources that failed:** Yahoo Finance (429, every symbol, all session), bls.gov (403),
  Kalshi `/markets` price fields (null via the list and detail endpoints; only trades/orderbook worked),
  `market_data.py events` (returns irrelevant matches), Alpha Vantage (no API key), Stooq (404 on indices),
  Finnhub for CFD indices (subscription required).

## [11:35 ET] ADDENDUM — budget remained after the completion block, so I went back for the small-cap gap.
Screened seven small caps surfaced by an "undervalued small caps with insider action" scan, then verified
every insider file directly against finnhub rather than trusting the article.
| Sym | buys | distinct buyers | $ bought | sells | $ sold | read |
| KMPR | 5 | **5** | $367,880 | **0** | $0 | **cluster — taken** |
| FSBC | 7 | 6 | $6,279,988 | 10 | $707,025 | rejected, see below |
| EVTC | 7 | 5 | $2,251,251 | 4 | $1,447,157 | real cluster, but at 29.98 vs buys at 23.37-26.42 — up 15-28% on them, no time to value it properly. **Watchlist.** |
| MBC  | 4 | 4 | $696,390 | 5 | $853,961 | net seller overall; cabinets into a hiking Fed is the worst possible sector fit. No. |
| RM   | 3 | 2 | $347,058 | **19** | $4,288,225 | two buyers against nineteen sellers is not a cluster. No. |
| AZTA | 2 | 2 | $171,896 | 0 | $0 | tiny ($172K) and one lot was 335 shares. Too thin to weight. |
| VALU | 1 | 1 | $6,778 | 0 | $0 | noise. |
- **REJECTED — FSBC, and the reason matters generally:** the dollar figure is the largest on the page
  ($6.28M, six buyers) but **all seven purchases are at exactly $44.00 on exactly 2026-07-22**. That is the
  signature of insiders subscribing to a capital raise at a fixed offering price, not of six people
  independently deciding the stock is cheap. finnhub codes it as an open-market buy; it should not be read
  as one. Five Star Bancorp also posted a $268.6M Q2 net loss. A dollar total is not a cluster — a
  distribution of dates and prices is.

## [11:36 ET] NEW IDEA CAPTURED — KMPR — the small-cap slot, filled properly rather than to fill it
- KMPR 27.93. **TTM EPS -$8.33 and -$495.5M net income, but forward P/E 8.85.** The gap is one line item:
  a **$460M NON-CASH goodwill impairment**, which Kemper states has no impact on the cash-generating
  ability of the businesses, statutory capital, holding company liquidity, or debt and revolver covenant
  compliance. The same quarter's adjusted profit **beat**, on improving underlying operating performance.
  Revenue $4.59B (-4.0%), dividend $1.28 = 4.58%, cap $1.65B on 58.92M shares.
  — sources: https://investors.kemper.com/news/news-details/2026/Kemper-Reports-Second-Quarter-2026-Operating-Results/default.aspx
             https://www.investing.com/news/company-news/kemper-q2-2026-slides-adjusted-profit-beats-despite-460m-impairment-93CH-4842372
- **INSIDER CLUSTER — the best of the whole morning: 5 buys, 5 distinct buyers, $367,880, ZERO sells,**
  spread across 2026-08-11 to 08-13 at $26.34 / $26.49 / $26.50 / $26.53. New CEO Stephen McAnena
  (appointed 2026-06-01) bought 3,000 at $26.50. Five people, five prices, three days — independent
  decisions, not an offering. Contrast FSBC above.
- The actual problem, stated not minimised: California bodily injury. Commercial auto reserves ~$1B with
  ~90% in bodily injury, and $17.7M of adverse prior-year development in the quarter. The fix is priced
  and dated — 5.5% average rate effective in Q2 with a further **6.9% filing pending** — and management
  says California personal auto needs double-digit increases to reach target profitability.
- LIQUIDITY (required disclosure, cap under $2B): ~880K shares/day x ~$28 = **~$24.6M average dollar
  volume**, roughly 50x the $500K floor. Cap $1.65B is above the $300M line, so 2.5% sizing is permitted.
- ARITHMETIC: target 42 (the *lower* of two Buy-rated targets — TD Cowen $42, UBS $43 — and ~9.3x a
  normalised $4.50 EPS, which is just the $1.12 Kemper earned in Q2 2025 annualised, i.e. a return to
  prior earnings power, not an expansion). Bear 21, **below the 52-week low of 22.69**, to allow for the
  reserves being short. At 27.93 → 2.03, fails. Floor breaks at 27.00; entry 26.90 = 2.56.
- Third independent case today where the floor-clearing entry landed on the insider purchase price
  (ELV 368.6 vs 366-368; CAG 14.66 vs 14.59; KMPR 27.00 vs 26.34-26.53). Noted in the 11:30 self-audit.
- Regime fit: a P&C insurer reinvesting float at higher-for-longer yields is one of the few things Warsh's
  hawkishness helps. Uncorrelated with the Iran/energy cluster, the Fed contract and the healthcare idea.
- 150-day: SMA20 27.63, SMA50 27.91, ATR14 3.55%, range 22.69-39.665, -29.6% off high, +23.1% off low.
  Consolidating flat on both averages — a base, not a downtrend.

## [11:37 ET] RESEARCH COMPLETE — REVISED (supersedes the 11:33 block)
- **candidates: 11 unique symbols**, 13 lines (KXFEDDECISION-26SEP-H0 and TJX were each revised and
  re-captured; synthesis takes the last entry per symbol).
  - Position/order actions (4): /MBTU6 cover (5), TJX close (5), EEM order cancel (4), LULU trim half (3).
  - New ideas (7): ELV (4), CME (4), MDT (4), CAG (3), ETH (3), **KMPR (3)**, Fed Sep no-hike (2).
- **The small-cap gap flagged at 11:33 is now closed by KMPR** ($1.65B cap, $24.6M ADV). SVRA remains
  rejected on its own arithmetic. Everything else in that gap list still stands.
- **EVTC added to the watchlist**, not recommended: a genuine 7-buy / 5-buyer / $2.25M cluster, but the
  stock at 29.98 is 15-28% above where they bought and I ran out of budget to value it honestly.
  Next run should start there.
- All other coverage gaps, failed sources and rejections as listed in the 11:33 block — that list is
  unchanged and still applies.

## [11:35 ET] EVTC — worked it rather than deferring it. Verdict: WATCHLIST, and here is the exact
question the next run has to answer before it can be a recommendation.
- EVTC 29.98, cap $1.79B on 59.75M shares. Revenue TTM $996.16M (+12.4%); **Q2 2026 revenue +20% YoY to
  $275M** on organic growth, acquisitions and FX. Morgan Stanley raised its target to $34 from $25
  (Equal Weight). Strategic agreement signed with Transbank, Chile's leading payment operator.
  150-day: SMA20 30.35, SMA50 29.51, ATR14 3.24%, range 21.81-34.41, -12.9% off high, +37.5% off low.
  52-week range 21.81-36.52. — source: https://stockanalysis.com/stocks/evtc/
- INSIDERS: 7 buys / 5 distinct buyers / $2.25M, against 4 sells / $1.45M. Six of the seven lots landed
  2026-05-07 to 05-12 at $22.03-24.33 — at the 150-day low — with Brian Smith adding 16,202 at $26.42 on
  06-12. The likely trigger: EVTC disclosed potential unauthorised access to customer data on 2026-05-13.
- **WHY I DID NOT CAPTURE IT, and this is the honest reason rather than a time excuse:**
  1. **Trailing P/E 19.35 versus forward P/E 7.21 implies forward EPS near $4.16 against $1.55 trailing.**
     For MDT and KMPR I took the same shape only because I had a documented one-off behind it — the
     MiniMed/Blackstone charges and a $460M goodwill impairment respectively. **Here I have no verified
     bridge.** For an acquisitive payments processor it is almost certainly acquisition amortisation, i.e.
     a GAAP-versus-adjusted comparison, and treating the two as the same number would be exactly the
     careless arithmetic this repo exists to catch. I will not build a target on a multiple I cannot explain.
  2. Unlike KMPR (0 sells) and CAG (0 sells), this cluster sits alongside $1.45M of insider selling.
  3. The stock is already 15-28% above where they bought, so the entry advantage is gone.
  4. Minor but worth noting: most of the buying occurred in the days immediately BEFORE the 05-13 breach
     disclosure. Not evidence of anything improper, but not a clean "they bought the bad news" story either.
- **NEXT RUN, START HERE:** pull the Q2 2026 10-Q or press release and reconcile GAAP EPS to adjusted EPS.
  If the $4.16 forward figure is adjusted and the cash conversion supports it, this is a 20%-growth
  payments business at a single-digit multiple with a five-buyer insider cluster, and it deserves a full
  workup. If the gap is just amortisation dressed up, it is a 19x stock and there is nothing here.

## [11:36 ET] FINAL — nothing further captured. Stopping deliberately, not from exhaustion.
Budget remained after the addendum. I chose not to spend it on another idea because nothing else in the
morning's work cleared the bar, and config/strategy.md is explicit that padding is worse than a short list.
Final state: **11 unique candidates** (13 lines, two deliberate revisions), 6 rejections written up with
reasons, one watchlist name with a specific unanswered question, and every price in this file traceable to
a fetched source with its own asof. The three things synthesis must carry into the report regardless of
how it ranks the ideas:
1. **The regime changed on Friday** — Warsh flipped the market from cuts to pricing hikes. Every level in
   the open book was set under the old regime.
2. **The open book is one bet on Iran** — six-plus of twenty positions resolve on the Strait of Hormuz,
   against a stated cap of three.
3. **Two stops were breached and ignored** (/MBTU6 -21.7%, TJX -10.4%). Closing them is the highest-ranked
   action in this file, and the /MBTU6 cover is now the third consecutive report to ask for it.
